Akebia Therapeutics to Report Third Quarter 2025 Financial Results and Discuss Recent Business Highlights

Core Viewpoint - Akebia Therapeutics, Inc. is set to release its financial results for Q3 2025 on November 10, 2025, before the market opens [1] Financial Results Announcement - The financial results will be discussed in a conference call scheduled for November 10, 2025, at 8:00 a.m. EST [2] - Participants are encouraged to register in advance to receive dial-in details and to join the call 15 minutes early to avoid delays [2] Webcast Information - A live webcast of the conference call will be available on Akebia's Investors section of their website, with an online archive accessible afterward [3] Company Overview - Akebia Therapeutics is a biopharmaceutical company focused on improving the lives of individuals affected by kidney disease, founded in 2007 and headquartered in Cambridge, Massachusetts [4]